Expand NBP Menu
NBP MENU

NBP Latest Press Releases

-- June 16, 2026 --

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer Globe Newswire 7:00 AM

-- May 28, 2026 --

NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 7:00 AM

-- May 12, 2026 --

NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference Globe Newswire 7:00 AM

-- April 22, 2026 --

NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value Globe Newswire 7:00 AM

-- April 7, 2026 --

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:50 PM

-- March 16, 2026 --

NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer Globe Newswire 7:00 AM

-- March 9, 2026 --

NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study Globe Newswire 7:00 AM

-- March 3, 2026 --

NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 Globe Newswire 9:05 AM

-- March 2, 2026 --

NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference Globe Newswire 7:00 AM

-- February 19, 2026 --

NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform Globe Newswire 7:00 AM

-- February 17, 2026 --

NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer Globe Newswire 4:05 PM

-- January 20, 2026 --

NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes